ArticleAmerican journal of translational research2024
Effect of minimally invasive strabismus surgery under a microscope on tear film function and ocular surface status in strabismus patients.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the effects of minimally invasive strabismus surgery (MISS) on tear film function and ocular surface status in patients with strabismus.
methodsWe respectively analyzed the clinical data from 173 cases of strabismus patients treated at Xi'an First Hospital from September 2021 to March 2024. The patients were classified into a minimally invasive group (n=91, undergoing MISS) and a conventional group (n=82, undergoing traditional strabismus correction) according to their treatment plans. The general data, treatment efficacy, tear film function, ocular surface status, perioperative indicators, pain, and visual recovery were compared between the two groups. Factors affecting the patients' postoperative recovery were further analyzed according to the treatment effects.
resultsThe clinical efficacy of the minimally invasive group (95.6%) was significantly higher than the conventional group (68.3%). Visual recovery of the minimally invasive group was also significantly better than the conventional group (
conclusionMISS effectively improves clinical outcomes in strabismus patients, preserves tear film function and ocular surface health, and promotes visual recovery. The Slt, CFS, and treatment regimen are independent factors affecting postoperative recovery in strabismus patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.